| Patents for A61P 9 - Drugs for disorders of the cardiovascular system (159,484) |
|---|
| 04/19/2007 | WO2006074924A8 3,4,(5)-substituted tetrahvdropyridines |
| 04/19/2007 | WO2006070022A3 Medicaments containing selenium for the treatment of endothelial vascular diseases |
| 04/19/2007 | WO2006029052A8 Methods for assessing atherosclerosis |
| 04/19/2007 | WO2005077950A3 Medicaments with hm74a receptor activity |
| 04/19/2007 | US20070088085 Use of benzylideneaminoguanidines and hydroxyguanidines as melanocortin receptor ligands |
| 04/19/2007 | US20070088068 E-series of prostaglandin (EP) receptors; reducing [4-(4,9-dipropoxy-1-oxo-1,3-dihydro-2H-benzo[f]isoindol-2-yl)phenyl]acetate to form [[4-(4,9-dipropoxy-1-oxo-1,3-dihydro-2H-benzo[f]isoindol-2-yl) phenyl]acetic acid |
| 04/19/2007 | US20070088059 Neuroprotectants; reduce side effect of neurotoxic agent; treatment of neuropathies resulting from chemotherapeutic agents used in the treatment of HIV and proliferative disease such as cancer and treatment of inflammatory diseases, neurodegenerative diseases |
| 04/19/2007 | US20070088033 Diaryl Substituted Pyridinones |
| 04/19/2007 | US20070088027 Carboxylic acid derivatives and pharmaceutical compositions comprising the same as an active ingredient |
| 04/19/2007 | US20070088008 treating psoriasis with e.g. 19-nor-2beta-ethyl-1alpha,25-dihydroxyvitamin D3 |
| 04/19/2007 | US20070087409 Angiotensin peptide-carrier conjugates and uses thereof |
| 04/19/2007 | US20070087388 G protein coupled receptor |
| 04/19/2007 | US20070087375 Methods and compositions for treating cancer using 2192, 2193, 6568, 8895, 9138, 9217, 9609, 9857, 9882, 10025, 20657, 21163, 25848, 25968, 32603, 32670, 33794, 54476 and 94710 |
| 04/19/2007 | US20070087342 Secreted proteins |
| 04/19/2007 | CA2675901A1 Compositions for the treatment and prevention of heart disease and methods of using same |
| 04/19/2007 | CA2672322A1 Method for detecting a biomarker of oxidative stress in a biological sample |
| 04/19/2007 | CA2627623A1 Methods for inhibiting protein kinases |
| 04/19/2007 | CA2626011A1 S1p3 receptor antagonist |
| 04/19/2007 | CA2625613A1 Egln2 variants and use thereof in preventing or treating thromboembolic disorders and coronary heart diseases |
| 04/19/2007 | CA2625150A1 Combined use of dpp-iv inhibitors and gastrin compounds |
| 04/19/2007 | CA2624584A1 Novel pharmaceutical combinations for the treatment of respiratory disorders |
| 04/19/2007 | CA2623563A1 Method of inhibiting angiogenesis by using ephrin b2 |
| 04/19/2007 | CA2623327A1 Nitrogenated heterocyclic compound and pharmaceutical composition comprising the same |
| 04/18/2007 | EP1775297A2 Adenosine receptor antagonists and methods of making and using the same |
| 04/18/2007 | EP1775293A1 Antiplatelet agent and process for producing the same |
| 04/18/2007 | EP1775288A1 Delta d Crystaline form of ivabradine hydrochloride, process of preparation thereof and pharmaceutical compositions containing the same |
| 04/18/2007 | EP1775287A1 Delta d Crystaline form of ivabradine hydrochloride, process of preparation thereof and pharmaceutical compositions containing the same |
| 04/18/2007 | EP1775283A1 3-aminobenamide compound and vanilloid receptor 1 (vr1) activity inhibitor |
| 04/18/2007 | EP1774967A1 Solid oral dosage forms comprising valsartan |
| 04/18/2007 | EP1773867A2 Proteinaceous compounds and uses therefor |
| 04/18/2007 | EP1773818A2 Preparation of hydrochloride salts of tetrazole derivative |
| 04/18/2007 | EP1773795A1 Substituted benzothiazoles |
| 04/18/2007 | EP1773780A2 Amido compounds and their use as pharmaceuticals |
| 04/18/2007 | EP1773450A2 Therapeutically combinations |
| 04/18/2007 | EP1773397A2 Composition comprising plant and/or fish oils and non-oxidizable fatty acid entities |
| 04/18/2007 | EP1773375A1 Netrin-related compositions and uses |
| 04/18/2007 | EP1773357A2 Compositions and methods of use of dimer digallates |
| 04/18/2007 | EP1773335A2 Nanoparticle dispersion containing lactam compound |
| 04/18/2007 | EP1773314A2 Use of l-carnitine for the treatment of cardiovascular diseases |
| 04/18/2007 | EP1773312A1 Composition containing statins and omega-3 fatty acids |
| 04/18/2007 | EP1476438B1 Oxa- and thiadiazoles and their use as metalloproteinase inhibitors |
| 04/18/2007 | EP1458386B1 Aroyl pyrrole heteroeryl and methanols useful for treating a central nervous system disorder |
| 04/18/2007 | EP1455792B1 Ureas of 2-aminobenzothiazoles as adenosine modulators |
| 04/18/2007 | EP1411970B1 Use of sarp-1 for the treatment and/or prevention of scleroderma |
| 04/18/2007 | EP1401479B1 Detection and therapy of vulnerable plaque with photodynamic compounds |
| 04/18/2007 | EP1379266B1 Modified annexin proteins and prevention and treatment of thrombosis |
| 04/18/2007 | EP1353662B1 Methods for the treatment of diseases using malonyl-coa decarbox ylase inhibitors |
| 04/18/2007 | EP1345918B1 1,5 benzothiazepines and their use as antihyperlipidemics |
| 04/18/2007 | EP1334194B1 Imaging, diagnosis and treatment of disease |
| 04/18/2007 | EP1326613B2 Use of substituted imidazo 1,2-a|pyridine-, imidazo ¬1,2-a|pyrimidine and imidazo ¬1,2-a|pyrazine-3-yl-amine derivatives for producing nos-inhibiting medicaments |
| 04/18/2007 | EP1192261B1 22025, a novel human cyclic nucleotide phosphodiesterase |
| 04/18/2007 | EP1137408B1 Agent for lowering endothelin levels |
| 04/18/2007 | EP1017390B1 Coated tablet comprising nicotinic acid or a compound metabolized to nicotinic acid in an extended release form, and a coating containing an hmg-coa reductase inhibitor in an immediate release form |
| 04/18/2007 | EP0956865B1 MEDICINES COMPRISING Rho KINASE INHIBITOR |
| 04/18/2007 | CN1950389A Nitrogenous fused-ring derivatives, medicinal compositions containing the derivatives, and use thereof as drugs |
| 04/18/2007 | CN1950372A 咪唑并吡啶化合物 Imidazopyridine compound |
| 04/18/2007 | CN1950352A Coumarin derivative and use thereof |
| 04/18/2007 | CN1950084A Perhexilin for treating chronic heart failure |
| 04/18/2007 | CN1950080A Novel compounds for treatment of cardiac arrhythmia and methods of use |
| 04/18/2007 | CN1948294A Amino acid diphenyl compound |
| 04/18/2007 | CN1948293A Delta d-crystalline form of ivabradine hydrochloride, a process for its preparation and pharmaceutical compositions containing it |
| 04/18/2007 | CN1948292A Delta;-crystalline form of ivabradine hydrochloride, a process for its preparation and pharmaceutical compositions containing it |
| 04/18/2007 | CN1947792A Method for preparing active protein composition type nano-selenium and its liquid phase storage tech. |
| 04/18/2007 | CN1947791A External use traditional Chinese medicine ointment for treating heart diseases |
| 04/18/2007 | CN1947780A Traditional Chinese medicine for treating coronary heart disease and angina pectoris |
| 04/18/2007 | CN1947763A Medicine for treating heart troubles and its prepn. method |
| 04/18/2007 | CN1947743A Application of Xuesilian for preparing medicine for treating hypertension |
| 04/18/2007 | CN1947736A Prepn. method and application of injection contg. Erigeron breviscapus |
| 04/18/2007 | CN1947732A Extraction method for primary active matter of edible fungi |
| 04/18/2007 | CN1947713A Nano-safflower flavone injection prepn. and its prepn. method |
| 04/18/2007 | CN1947712A Nano-safflower uranidin injection prepn. and its prepn. method |
| 04/18/2007 | CN1947711A Application of glutamine for preparing medicine for treating and preventing cellular sugar deficiency injury |
| 04/18/2007 | CN1947708A Time selecting released prepn. contg. angiotensin II 1 receptor antagonist |
| 04/18/2007 | CN1947686A Salt-solution with health-care function |
| 04/18/2007 | CN1311238C Hypotensors |
| 04/18/2007 | CN1311081C Stem cell differentiation |
| 04/18/2007 | CN1310950C Telerance starch made of starch of de-amylopectin by iso-anylase |
| 04/18/2007 | CN1310949C Bifunctional chimeric profein possessing inhibiting leucocyte function and thrombin activity |
| 04/18/2007 | CN1310940C Process for producing triterpene derivative |
| 04/18/2007 | CN1310921C Bicyclic oxopyridine and oxopyrimidine derivatives |
| 04/18/2007 | CN1310916C Hetero-bicyclic compounds |
| 04/18/2007 | CN1310915C Pyrido(2,1-a)isoquinoline derivatives as DPP-IV inhibitors |
| 04/18/2007 | CN1310909C Novel heteroaryl derivatives, their prepn. and use |
| 04/18/2007 | CN1310908C Rapamycin 29-enols |
| 04/18/2007 | CN1310906C Indole-type derivatives as inhibitors of p38 kinase |
| 04/18/2007 | CN1310900C Bi-aromatic compounds and pharmaceutical and cosmetic compositions containing the same |
| 04/18/2007 | CN1310881C New 3-aryl-2-hydroxypropionic acid derivative I |
| 04/18/2007 | CN1310870C Enantiomerically enriched 1-phenylethylamines |
| 04/18/2007 | CN1310679C Method of achieving persistent transgene expression |
| 04/18/2007 | CN1310662C Chinese medicine for coronary heart disease |
| 04/18/2007 | CN1310660C Formulation for treating coronary heart disease and angina pectoris and its preparing process |
| 04/18/2007 | CN1310654C Medicament for treatment of gynecologic diseases and preparation method |
| 04/18/2007 | CN1310650C Application of saponins in the preparing process of coxsackie virus resisting medicine |
| 04/18/2007 | CN1310643C Composition comprising a cholesterol absorption inhibitor, an HMG-CoA reductase inhibitor and a stabilizing agent |
| 04/18/2007 | CN1310635C Medicine composition for treating cardiovascular and cerebrovascular diseases and preparation method thereof |
| 04/17/2007 | USRE39576 Inhibitors of inducible nitric oxide synthase, as hypotensive agent, antiinflammatory agent, antiarthritic agent |
| 04/17/2007 | USRE39575 For therapy of sleep, eating and brain disorders, wakefulness promoters; Parkinson's disease, antiischemic agents, stroke, chronic fatigue syndrome; antidepressants; schizophrenia, nervous system disorders; multiple sclerosis, cognition activators |
| 04/17/2007 | US7205417 Spiro compounds |
| 04/17/2007 | US7205403 Preferential G protein coupled receptor antagonists, such as 8-(3-amino-1-methyl-1H-pyrazol-5-yl)-1,3-dipropyl-3,7-dihydro -1H-purine-2,6-dione, used for prophylaxis of asthma, autoimmune diseases or retinopathy |
| 04/17/2007 | US7205392 Synergistic mixture of glycoprotein and angiogenesis inhibitor |